Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breztri Aerosphere in Moderate to Severe COPD
NCT06531798Phase 4Recruiting
- Sponsor
- AstraZeneca
- Start
- Jan 2026
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Breztri Aerosphere in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jan 2026; status: recruiting.
02
Drugs
Breztri Aerosphere
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT06531798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06531798.